SCHEMBL9871276

SCHEMBL9871276

CCOC(=O)c1cc(O)c2ccc3c(c2c1-c1cc(OC)c(OC)c(OC)c1)OCO3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD17B10 Q99714 3/20 0.39
TSHR P16473 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2954233 0.74 PRKCI (0.49) MEN1KMT2AL3MBTL1NPC1ALDH1A1
SCHEMBL9871266 0.73 MEN1 (0.42) MEN1KMT2AL3MBTL1NPC1ATM
SCHEMBL9327972 0.71 LMNA (0.42) MEN1KMT2AL3MBTL1NPC1ATM
SCHEMBL2952186 0.70 PRKCI (0.52) L3MBTL1NPC1ALDH1A1KDM4EMAPT
SCHEMBL9860617 0.67 SLC10A2 (0.48) MEN1KMT2AL3MBTL1NPC1ALDH1A1
SCHEMBL9860541 0.67 TUBB4A (0.54) MEN1KMT2AL3MBTL1NPC1ATM
SCHEMBL9329585 0.67 LMNA (0.39) MEN1KMT2AL3MBTL1NPC1ATM
SCHEMBL11367616 0.67 ALDH1A1 (0.52) MEN1KMT2AL3MBTL1NPC1ALDH1A1
SCHEMBL9015832 0.67 PDE3B (0.49) KDM4EHSD17B10
SCHEMBL10049626 0.65 MAPT (0.58) MEN1KMT2ANPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5011948-A Cleavage of isoxazole rings, reduction to amine, cyclization, lactonization; anticarcinogenic agents BRISTOL-MYERS COMPANY (US) 1991-04-30 US disclosed